Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Panzara, MD, MPH
Biogen
Study Director - Richard A Rudick, MD
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitatsklinik Fur Neurologie
Graz, Austria
- Universitatsklinik Fur Neurologie
Innsbruck, Austria
- Hopital Universitaire U.L.B. Erasme
Brussels, Belgium
- Elisabeth Ziekenhuis
Sijsele, Belgium
- Hopital Pellegrin Tripode, Neurologie
Bordeaux, France
- Hopital Neurologique Pierre Werth
Lyon, France
- Judisches Krankenhaus
Berlin, Germany
- Universitaetsklinikum Giessen, Oberarzt Neurologie
Giessen, Germany
- Medizinische Hochschule Hannover, Neurologische Klinik
Hanover, Germany
- Neurologische Abteilung
Henningsdorf, Germany
- Städtische Kliniken Osnabrück
Osnabrück, Germany
- Asklepios Klinik Schildautal
Seesen/Harz, Germany
- Fachbereich Neurologie Und Klinische Neurophysiologie
Wiesbaden, Germany
- Hadassah Hebrew Uni Hospital, Department of Neurology
Jerusalem, Israel
- Sheba Medical Center, Ms Center
Tel Litwinsky, Israel
- Universita Di Genova, Clinica Neurologica
Genova, Italy
- University of Alabama-Birmingham, Department of Neurology
Birmingham, Alabama, United States
- Phoenix Neurological Associates, Ltd.
Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California - Irvine
Irvine, California, United States
- Usc Ms Comprehensive Care Center
Los Angeles, California, United States
- Kaiser-Permanente Medical Center
Redwood City, California, United States
- Ms Center at Ucsf
San Francisco, California, United States
- Healthsouth Rehabilitation Hospital
Colorado Springs, Colorado, United States
- University of Colorado Ms Center
Denver, Colorado, United States
- Griffin Hospital
Derby, Connecticut, United States
- George Washington University Ms Center
Washington D.C., District of Columbia, United States
- Georgetown Univesity Hospital, Research Pharmacy
Washington D.C., District of Columbia, United States
- North Ridge Neuroscience Center
Fort Lauderdale, Florida, United States
- Maitland Neurology
Maitland, Florida, United States
- University of Miami, Department of Neurology
Miami, Florida, United States
- the Multiple Sclerosis Center of Atlanta
Atlanta, Georgia, United States
- Marietta Neurological Associates
Marietta, Georgia, United States
- Northwestern University, Department of Neurology
Chicago, Illinois, United States
- Rush-Presbyterian St. Luke'S Medical Center
Chicago, Illinois, United States
- Alexian Brothers Center for Clinical Research
Elk Grove Village, Illinois, United States
- Loyola Medical Center
Maywood, Illinois, United States
- Consultants in Neurology Northbrook
Northbrook, Illinois, United States
- Springfield Clinic Neuroscience Institute
Springfield, Illinois, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2002
- Primary completion
- 30 Apr 2005
- Completion
- 31 Dec 2005
- Last update posted
- 18 Jun 2009
- Registered enrollment
- 1,200
- Registry id
- NCT00030966
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.